HIV Drug Project Would Aim For A Cure
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry/government/academia collaboration would produce a new portfolio of drugs to eradicate the virus from tissue reservoirs where it lies latent, providing possible drug-free remission and potentially a cure:
You may also be interested in...
Infectious Diseases Space Wide Open For Partnering Beyond Hep C, Conference Finds
The recent spotlight on hepatitis C doesn't mean that's the only hot area in infectious diseases for deals.
Infectious Diseases Space Wide Open For Partnering Beyond Hep C, Conference Finds
The recent spotlight on hepatitis C doesn't mean that's the only hot area in infectious diseases for deals.
J&J’s Intelence Approved For HIV Treatment In NNRTI-Resistant Patients
Johnson & Johnson’s Tibotec unit prices etravirine at wholesale acquisition cost of $5.45, firm tells “The Pink Sheet” DAILY.